Folic Acid/Alzheimer’s Clinical Trial Planned By NIH-Funded Consortium
This article was originally published in The Tan Sheet
Executive Summary
A consortium of NIH-sponsored Alzheimer's research centers plans to conduct a clinical trial that will examine the effect of folic acid, and possibly other vitamins and supplements, on the disease, the National Institute on Aging said
You may also be interested in...
Research In Brief
Butterbur vs. Zyrtec: Herbal "should be considered for treating seasonal allergic rhinitis when the sedative effects of antihistamines need to be avoided," Andreas Schapowal, et al., Petasites Study Group, report in Jan. 19 British Medical Journal. In a randomized, double-blind trial, the German and Swiss researchers compared efficacy, tolerability of Petasites hybridus with cetirizine (Pfizer's Zyrtec) in 125 hay fever sufferers for two weeks. Effects of two treatments were comparable, researchers report, adding "butterbur was well tolerated and did not have the sedative effects associated with antihistamines. Fatigue and drowsiness accounted for two-thirds of adverse events reported in the antihistamine group"...
Ginkgo Dementia Prevention Trial Will Be Funded With $15 Mil.
The NIH National Center for Complementary and Alternative Medicine and the National Institute on Aging are inviting applications for a study in the prevention of cognitive dementia in older people that will be supported with up to $15 mil.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC